Smith (DS) PLC
26 March 2004
NOT FOR PUBLICATION, DISTRIBUTION OR TRANSMISSION, DIRECTLY OR INDIRECTLY IN OR
INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH
AFRICA.
26 March 2004
DS SMITH PLC
RESULT OF THE RIGHTS ISSUE
98.5% take up of DS Smith Rights Issue
DS Smith PLC ('DS Smith') today announces that it has received valid acceptances
in respect of 63,563,583 new DS Smith shares, representing 98.5% of the total
number of new DS Smith shares offered to shareholders pursuant to the 1 for 5
Rights Issue announced on 3 March 2004 (the 'Rights Issue'). A total of
64,540,651 new DS Smith shares were offered to shareholders in the Rights Issue,
which closed at 11.00 a.m. today.
Subscribers have been procured for the remaining 977,068 new DS Smith shares,
for which valid acceptances were not received, at a price of 162 pence per
share. The net proceeds from the sale of these shares, after the deduction of
the Rights Issue price of 112 pence per new DS Smith share and relevant costs,
will be paid to shareholders who have not taken up their entitlements, pro rata
to their lapsed provisional allotments (save that if the proceeds due to any
person do not exceed £3, the proceeds will be retained by DS Smith for the
benefit of all shareholders).
The Rights Issue was fully underwritten by Cazenove & Co. Ltd. As a result of
the procurement of subscribers, neither the underwriter nor the sub-underwriters
will be required to subscribe for any new DS Smith shares.
Enquiries
DS Smith Plc 020 7932 5000
Tony Thorne, Group Chief Executive
Gavin Morris, Group Finance Director
Cazenove & Co. Ltd 020 7588 2828
Malcolm Moir/Dermot McKechnie
Financial Dynamics 020 7269 7291
Richard Mountain/Robert Gurner
This announcement does not constitute, or form part of, an offer or solicitation
of an offer, to purchase or subscribe for any rights, shares or other securities
in DS Smith
This announcement is not an offer for sale of securities in or into the United
States, Canada, Japan, Australia, the Republic of South Africa or in any other
jurisdiction. The securities referred to herein may not be offered or sold in
or into the United States as such term is defined in Regulation S under the US
Securities Act 1933, as amended (the 'Securities Act') absent registration
under, or an exemption from such registration under, the Securities Act. There
will be no public offer of securities in the United States.
Cazenove is acting exclusively for DS Smith and no one else in connection with
the Rights Issue and will not be responsible to anyone other than DS Smith for
providing the protections afforded to clients of Cazenove nor for providing
advice in relation to the Rights Issue.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.